Finance

Beta
Lists
NAM:BKK
Namwiwat Medical Corp PCL
THB 3.56
0.00%
(0.00) 1D
Jun 10, 3:25:57 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for NAM...
Open
THB 3.56
High
THB 3.56
Low
THB 3.54
Mkt. cap
2.49B
Avg. vol.
31.80K
Volume
3.00K
Dividend
3.65%
Quarterly dividend
THB 0.03
Ex-dividend date
Mar 13, 2026
P/E ratio
34.64
52-wk high
THB 4.40
52-wk low
THB 3.20
EPS
THB 0.10
Shares outstanding
700.00M
No. of employees
457
Open
THB 3.56
High
THB 3.56
Low
THB 3.54
Mkt. cap
2.49B
Avg. vol.
31.80K
Volume
3.00K
Dividend
3.65%
Quarterly dividend
THB 0.03
Ex-dividend date
Mar 13, 2026
P/E ratio
34.64
52-wk high
THB 4.40
52-wk low
THB 3.20
EPS
THB 0.10
Shares outstanding
700.00M
No. of employees
457
News stories
From sources across the web
About Namwiwat Medical Corp PCL
CEO-
Employees457
Founded1970
Headquarters-
SectorMedical device
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
389.71M
487.37M
454.24M
377.25M
Cost of goods sold
294.22M
341.23M
325.95M
260.12M
Cost of revenue
294.22M
341.23M
325.95M
260.12M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
91.57M
106.30M
99.85M
97.95M
Operating expense
91.57M
106.30M
99.85M
97.95M
Total operating expenses
385.79M
447.53M
425.81M
358.07M
Operating income
3.92M
39.84M
28.43M
19.18M
Other non operating income
4.68M
376.20K
25.21K
1.48M
EBT including unusual items
3.21M
34.21M
31.16M
18.03M
EBT excluding unusual items
3.21M
34.21M
30.35M
18.03M
Income tax expense
-3.07M
8.25M
2.89M
5.88M
Effective tax rate
-95.76%
24.13%
9.28%
32.60%
Other operating expenses
-
-
-
-
Net income
8.69M
22.10M
30.79M
6.59M
Net profit margin
2.23%
4.53%
6.78%
1.75%
Earnings per share
-
-
-
-
Interest and investment income
1.14M
1.88M
2.20M
1.64M
Interest expense
-6.53M
-7.89M
-2.01M
-4.27M
Net interest expenses
-5.39M
-6.01M
188.90K
-2.63M
Depreciation and amortization charges
-
-
-
-
EBITDA
15.63M
53.44M
48.75M
34.02M
Gain or loss from assets sale
97.02K
1.99M
-2.29M
-378.63K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more